Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAPPYACTS 2: Molecular Profiling for Pediatric and Young Adult Cancer Treatment Stratification
NCT05691608Recruiting
- Sponsor
- Gustave Roussy
- Start
- Sep 2022
- Primary completion
- Sep 2030
- Countries
- 1
01
Overview
Single-arm trial in solid tumor and leukemia, sponsored by Gustave Roussy. Primary endpoints: Overall survival at 3 years, Number of additional technologies and new treatment strategies introduced at 3 years and 1 more. Started Sep 2022; status: recruiting.
02
Conditions
solid tumorleukemia
Beyond the preview
Go deeper on NCT05691608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05691608.